VALIDATION OF THE RISK OF RELAPSE IN CENTRAL NERVOUS SYSTEM (CNS) BY CNS-IPI IN DIFFUSE LARGE B-CELL LYMPHOMA (LDCBG) TREATED WITH R-CHOP: STUDY OF THE GELTAMO GROUP

被引：0
|
作者：
Franch Sarto, M. [1 ]
Garcia Calduch, O. [1 ]
Baile Gonzalez, M. [2 ,3 ]
Martin Garcia-Sancho, A. [2 ,3 ]
Garcia Pallarols, F. [4 ]
Salar Silvestre, A. [4 ]
Gutierrez Garcia, A. M. [5 ]
Bastos Oreiro, M. [6 ]
Rodriguez Salazar, M. J. [7 ]
Gonzalez de Villambrosia, S. [8 ]
Mendez Lopez, A. M. [8 ]
Zato Hernandez, E. [9 ]
Cordoba Mascunano, R. [10 ]
Martin Moreno, A. M. [11 ]
Diaz Lopez, A. [11 ]
Luzardo Henriquez, H. D. [12 ]
Garcia Belmonte, D. [13 ]
Hong, A. [14 ]
Moreno Velazquez, M. [1 ]
Penalver Parraga, F. J. [15 ]
Montalban Sanz, C. [11 ]
Sancho Cia, J. M. [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[2] Hosp Univ, Salamanca, Spain
[3] IBSAL, Salamanca, Spain
[4] Hosp Mar, Barcelona, Spain
[5] Hosp Univ Son Espases, Palma De Mallorca, Spain
[6] Hosp Gregorio Maranon, Madrid, Spain
[7] Hosp Univ Canarias, Canarias, Spain
[8] Hosp Univ Marques de Valdecilla, Santander, Spain
[9] Hosp Gen Segovia, Segovia, Spain
[10] Fdn Jimenez Diaz, Madrid, Spain
[11] MD Anderson Canc Ctr, Madrid, Spain
[12] Hosp Univ Gran Canarias Dr Negrin, Las Palmas Gran Canaria, Spain
[13] Hosp Zarzuela, Madrid, Spain
[14] Hosp Lanzarote, Lanzarote, Spain
[15] Hosp Univ Fdn Alcorcon, Madrid, Spain
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-007
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [31] Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
    Guirguis, Hany R.
    Cheung, Matthew C.
    Mahrous, Mervat
    Piliotis, Eugenia
    Berinstein, Neil
    Imrie, Kevin R.
    Zhang, Liying
    Buckstein, Rena
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) : 39 - 49
  • [32] Large B-cell lymphoma of the retina, vitreous and central nervous system (CNS).
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2238 - 2238
  • [33] Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with RCHOP/R-CHOP-like in a Single Institution
    Gay, Maria Queralt Salas
    Mercadal, Santiago
    Domenech, Eva Domingo
    Oliveira, Ana C.
    Encuentra, Maite
    Climent, Fina
    Cano, Cristina Baca
    Andrade-Campos, Marcio
    De la Banda, Esmeralda
    Aguilera, Carmen
    de Sevilla, Alberto Fernandez
    Sureda, Anna
    Gonzalez-Barca, Eva
    BLOOD, 2017, 130
  • [34] Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.
    Kim, Seok Jin
    Park, Yong
    Lee, Soon Il
    Eom, Hyeon Seok
    Kim, Jin Seok
    Kim, Min Kyoung
    Do, Young Rok
    Yoon, Dok Hyun
    Won, Jong-Ho
    Mun, Yeung-Chul
    Lee, Won Sik
    Kang, Hye Jin
    Kim, Hyo Jung
    Kwon, Jung Hye
    Kim, Jeong-A
    Kwak, Jae-Yong
    Lee, Jae Hoon
    Kong, Jee Hyun
    Oh, Sung Yong
    Lee, Sun Ah
    Park, Eun Kyung
    Bae, Sung Hwa
    Lee, Je-Jung
    Kim, Yang Soo
    Chang, Myung Hee
    Jun, Hyun Jung
    Kim, Won Seog
    Suh, Cheolwon
    BLOOD, 2012, 120 (21)
  • [35] Integration of mutation analysis as a risk predictor in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Song, Joo
    Perry, Anamarija
    Herrera, Alex F.
    Skrabek, Pamela
    Nasr, Michel
    Ottesen, Rebecca
    Nikowitz, Janet
    Chen, Lu
    Bedell, Victoria
    Murata-Collins, Joyce
    Chen, Yuan Yuan
    Li, Yuping
    Luna, Carlos Gomez
    McCarthy, Christine
    Pillai, Raju
    Wang, Jinhui
    Wu, Xiwei
    Zain, Jasmine
    Nademanee, Auayporn P.
    Niland, Joyce
    Gong, Qiang
    Chan, Wing Chung
    Weisenburger, Dennis D.
    MODERN PATHOLOGY, 2018, 31 : 556 - 556
  • [36] Integration of mutation analysis as a risk predictor in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Song, Joo
    Perry, Anamarija
    Herrera, Alex F.
    Skrabek, Pamela
    Nasr, Michel
    Ottesen, Rebecca
    Nikowitz, Janet
    Chen, Lu
    Bedell, Victoria
    Murata-Collins, Joyce
    Chen, Yuan Yuan
    Li, Yuping
    Luna, Carlos Gomez
    McCarthy, Christine
    Pillai, Raju
    Wang, Jinhui
    Wu, Xiwei
    Zain, Jasmine
    Nademanee, Auayporn P.
    Niland, Joyce
    Gong, Qiang
    Chan, Wing Chung
    Weisenburger, Dennis D.
    LABORATORY INVESTIGATION, 2018, 98 : 556 - 556
  • [37] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [38] Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP
    Kadota, Tomohiro
    Seo, Sachiko
    Fuse, Hiroe
    Ishii, Genichiro
    Itoh, Kuniaki
    Yano, Tomonori
    Kaneko, Kazuhiro
    Tsukasaki, Kunihiro
    CANCER MEDICINE, 2019, 8 (03): : 982 - 989
  • [39] Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
    Lavacchi, Daniele
    Landini, Ida
    Perrone, Gabriele
    Roviello, Giandomenico
    Mini, Enrico
    Nobili, Stefania
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [40] Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
    Choi, Soyeon
    Lee, Yoo Jin
    Choi, Yunsuk
    Kim, Misung
    Kim, Hyun-Jung
    Kim, Ji Eun
    Oh, Sukjoong
    Chae, Seoung Wan
    Cha, Hee Jeong
    Jo, Jae-Cheol
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (05) : 281 - 288
12345